Mycotic vulvovaginitis: a broad overview.
The incidence of mycotic vulvovaginitis is rising dramatically in the United States mainly because of an increase in infections caused by Candida species. Accurate diagnosis depends on culture techniques that will yield correct identification of fungal pathogen(s). Recurrences are common and require culture specimens from sexual partners and appropriate antifungal therapy. The imidazoles and more recently the broader spectrum triazoles are used for vaginal therapy.
Horowitz
B J
BJ
Department of Obstetrics and Gynecology, University of Connecticut School of Medicine, Hartford.
D000935:Antifungal Agents / Q000737:chemistry / Q000627:therapeutic use; D002175:Candida / Q000166:cytology / Q000302:isolation & purification / Q000378:metabolism; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy / Q000382:microbiology*; D002473:Cell Wall / Q000737:chemistry; D065607:Cytochrome P-450 Enzyme Inhibitors; D004875:Ergosterol / Q000037:antagonists & inhibitors; D005260:Female; D006801:Humans; D009181:Mycoses / Q000188:drug therapy / Q000382:microbiology; D012008:Recurrence
D000935:Antifungal Agents; D065607:Cytochrome P-450 Enzyme Inhibitors; D004875:Ergosterol